p21 Ras (HRAS) Rabbit Polyclonal Antibody

CAT#: TA326254

Rabbit polyclonal RASH/RASK/RASN antibody

Product Images

Western blot analysis of extracts from HeLa cells, using RASH/RASK/RASN antibody (#TA326254).The lane on the right is treated with the synthesized peptide.

• 

  Immunohistochemical analysis of paraffin-embedded human brain tissue using RASH/RASK/RASN antibody (#TA326254).The picture on the right is treated with the synthesized peptide.

Specifications

Product Data

• Applications: IHC, WB
• Recommended Dilution: WB: 1:500~1:3000 IHC: 1:50~1:100ELISA: 1:20000
• Reactivities: Human, Mouse, Rat
• Host: Rabbit
• Isotype: IgG
• Clonality: Polyclonal
• Immunogen: The antiserum was produced against synthesized peptide derived from human RASH/RASK/RASN antibody.
• Formulation: Phosphate buffered saline (without Mg2+ and Ca2+), pH 7.4, 150mM NaCl, 0.02% sodium azide and 50% glycerol.
• Concentration: lot specific
• Purification: The antibody was affinity-purified from rabbit antiserum by affinity-chromatography using epitope-specific immunogen.
• Conjugation: Unconjugated
• Storage: Store at -20°C as received.
• Stability: Stable for 12 months from date of receipt.
• Gene Name: Harvey rat sarcoma viral oncogene homolog
• Database Link:
  NP_005334
  Entrez Gene 15461 MouseEntrez Gene 293621 RatEntrez Gene 3265 Human
  UniProt ID P01112
• Synonyms: C-BAS; C-H-RAS; C-HA-RAS1; CTLO; H-RASIDX; HAMSV; HAS; HRAS1; p21ras; RASH1

Reference Data

• Protein Families: Druggable Genome
• Protein Pathways: Acute myeloid leukemia, Axon guidance, B cell receptor signaling pathway, Bladder cancer, Chemokine signaling pathway, Chronic myeloid leukemia, Endocytosis, Endometrial cancer, ErbB signaling pathway, Fc epsilon RI signaling pathway, Focal adhesion, Gap junction, Glioma, GnRH signaling pathway, Insulin signaling pathway, Long-term depression, Long-term potentiation, MAPK signaling pathway, Melanogenesis, Melanoma, Natural killer cell mediated cytotoxicity, Neurotrophin signaling pathway, Non-small cell lung cancer, Pathways in cancer, Prostate cancer, Regulation of actin cytoskeleton, Renal cell carcinoma, T cell receptor signaling pathway, Thyroid cancer, Tight junction, VEGF signaling pathway